- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04896502
Effectiveness of Telemedicine Home Assessments for Identification and Reduction of Asthma Triggers
September 6, 2022 updated by: University of Arkansas
The study is about comparing asthma home assessments/interventions by telemedicine compared to providing education alone.
Interactive Video (IAV) defines telemedicine.
It allows two-way communication in real-time with both audio and visual communication between the subject and someone from the study team.
It is similar to using Face Time on a mobile device.
Asthma home assessments/interventions are used to identify things in a home that can make asthma symptoms worse, called triggers.
Reducing these triggers in the home can improve asthma.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In this study, supplies will be given to some participants to help reduce or remove triggers from the home.
One example is dust mites.
These are microscopic bugs that are found in every home, cannot be seen by the naked eye, and make asthma symptoms worse.
Part of the study includes collecting two dust samples from home to check dust mite levels at the beginning of the study and at the end.
This study may help elucidate whether telemedicine home assessments work better than education alone at lowering dust mite levels and improving a child's asthma symptoms.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72202
- Arkansas Children's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age ≥ 5 years and ≤ 18 years
- Have a diagnosis of persistent asthma as defined by national guidelines criteria1
- Patient receives care in Arkansas Children's Hospital (ACH) primary care, in patient and/or specialty clinics
- Patient has had at least one or more acute exacerbations of asthma within the 12 months prior to enrollment that led to an emergency department visit, hospital admission, or prescription for systemic steroids
- English speaking participants/parents
- Access to WIFI, smartphone or mobile device (tablet)
Exclusion Criteria:
- Age <5 or >18 years
- Non-English speaking participants/parents
- Patients not receiving primary and/or asthma specialty care or inpatient services at ACH
- Inability of patient or family to participate in TM evaluation due to lack of access to WIFI or smartphone or mobile device
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Telemedicine Arm
For the proposed study, participants will randomized to receive TM home assessments/interventions performed by a trained home visitor (HV) or standard of care asthma trigger education by the HV.
Those who are randomized to TM home assessments/interventions will complete a baseline home assessment and two follow-up visits, 2 months apart.
Visits will assess the presence of potential asthma triggers in the home and frequency of asthma symptoms/exacerbations.
TM participants will be provided education and materials necessary to reduce asthma triggers in the home.
Follow-up visits will assess the interval change in presence of asthma triggers, change in daily asthma symptoms/exacerbations, and participant/family retention of education.
|
Interactive video assessment of asthma triggers in the home.
|
Active Comparator: Standard of Care Education
For subjects randomized to receive standard of care asthma education, written and verbal information will be provided regarding identification and removal of potential asthma triggers in the home but no formal assessment of the home will be performed, nor will participants in this arm receive trigger reduction materials.
|
Education regarding recognition and removal of in-home asthma triggers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in asthma-related triggers
Time Frame: 4 months
|
Changes in dust mite levels in home collected dust
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Asthma Control Test (ACT)
Time Frame: 6 months
|
from baseline to 6 months
|
6 months
|
Changes in healthcare utilization
Time Frame: 6 months
|
measured as either an increase or decrease in visits to a healthcare provider and/or medication pick-up from baseline to end of study
|
6 months
|
Patient Satisfaction
Time Frame: 6 months
|
as assessed via survey
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Robert Pesek, MD, University of Arkansas
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 26, 2019
Primary Completion (Actual)
August 8, 2022
Study Completion (Actual)
September 1, 2022
Study Registration Dates
First Submitted
May 11, 2021
First Submitted That Met QC Criteria
May 17, 2021
First Posted (Actual)
May 21, 2021
Study Record Updates
Last Update Posted (Actual)
September 7, 2022
Last Update Submitted That Met QC Criteria
September 6, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 239759
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthma in Children
-
Istituto di Farmacologia Traslazionale - sede di...Not yet recruitingAsthma in Children | Children, Only | Serious Game
-
University of FloridaNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruitingAsthma in ChildrenUnited States
-
ResMedCompletedAsthma in ChildrenUnited States
-
University of WashingtonNational Institute of Environmental Health Sciences (NIEHS); National Institute... and other collaboratorsCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Duke UniversityRecruitingAsthma in ChildrenUnited States
-
Rambam Health Care CampusCompleted
-
Shaoxing Maternity and Child Health Care HospitalRecruiting
-
University of LiverpoolNot yet recruiting
Clinical Trials on Interactive Video (IAV) Telemedicine
-
Helse Stavanger HFCompletedChronic Obstructive Pulmonary Disease (COPD)Norway
-
University of RochesterPatient-Centered Outcomes Research Institute; National Parkinson FoundationCompletedParkinson DiseaseUnited States
-
University of SheffieldNot yet recruitingLanguage Development Disorders
-
University of North Carolina, Chapel HillUS Department of Veterans Affairs; American Foundation for Suicide PreventionCompleted
-
National Taiwan University HospitalUnknownNursing | PsychiatryTaiwan
-
Mount Sinai Hospital, CanadaCrohn's and Colitis CanadaUnknownInflammatory Bowel Diseases | Crohn Disease | Medication Adherence | Ulcerative ColitisCanada
-
McGill UniversityUniversité du Québec à Trois-Rivières; Université de Montréal; Concordia University... and other collaboratorsRecruiting
-
Breathe California, Los Angeles CountyCompletedPulmonary Disease, Chronic Obstructive
-
Taipei Medical University HospitalCompleted
-
Taipei Medical University HospitalCompleted